CAITLIN COOK: Open Payments
NPI 1184029175 · CASTLETON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,175 in 108 payments from 16 companies in 2025. Trend: 2023 $874 · 2024 $2,342 · 2025 $2,175
Food & beverage: $2,170Education: $5
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $641 |
| Regeneron Healthcare Solutions, Inc. | 5 | $313 |
| Janssen Biotech, Inc. | 12 | $297 |
| Novartis Pharmaceuticals Corporation | 16 | $279 |
| Galderma Laboratories, L.P. | 16 | $138 |
| Alexion Pharmaceuticals, Inc. | 1 | $123 |
| GENZYME CORPORATION | 4 | $107 |
| Lilly USA, LLC | 3 | $48 |
| Amgen Inc. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, COSENTYX, NEMLUVIO, KOSELUGO, TALTZ, OTEZLA.
Industry payments across NY — which companies pay providers there.
